Ichor Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ichor Therapeutics's estimated annual revenue is currently $4M per year.
- Ichor Therapeutics's estimated revenue per employee is $77,500
- Ichor Therapeutics's total funding is $4.5M.
Employee Data
- Ichor Therapeutics has 52 Employees.
- Ichor Therapeutics grew their employee count by 21% last year.
Ichor Therapeutics's People
| Name | Title | Email/Phone |
|---|
Ichor Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Ichor Therapeutics?
Since its founding in 2013, Ichor has studied fundamental mechanisms of aging to develop new classes of drugs dedicated to helping people live longer, healthier lives. Building a successful company is a consequence of what we do in the pursuit of our vision. We are intrinsically motivated to create positive change in the world because we believe we can. Ichor operates from its corporate offices and research laboratories in rural LaFayette, NY (just south of Syracuse). The company is eager to engage collaborators and clients in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.
keywords:N/A
$4.5M
Total Funding
52
Number of Employees
$4M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ichor Therapeutics News
Biological Defense Market to Witness Robust Expansion by 2029 ... The New York Irish Emgirant
Other Companies in LaFayette
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.6M | 52 | 2% | N/A |
#2 | $10.6M | 52 | 8% | N/A |
#3 | $15.4M | 52 | 6% | N/A |
#4 | $3.5M | 52 | 2% | N/A |
#5 | $11.5M | 52 | 4% | N/A |